JOHN SHARKEY: Open Payments
NPI 1336532456 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,035 in 45 payments from 14 companies in 2025. Trend: 2023 $1,241 · 2024 $1,406 · 2025 $1,035
Food & beverage: $1,035
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $348 |
| Amgen Inc. | 6 | $120 |
| AKEBIA THERAPEUTICS INC | 4 | $97 |
| Calliditas Therapeutics US Inc. | 3 | $94 |
| Mallinckrodt Hospital Products Inc. | 3 | $86 |
| Alexion Pharmaceuticals, Inc. | 3 | $59 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
| Travere Therapeutics, Inc. | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Fresenius USA Marketing, Inc. | 2 | $37 |
Products named: Fabhalta, Vafseo, TARPEYO, ACTHAR, ULTOMIRIS, TAVNEOS, JARDIANCE, KRYSTEXXA.
Industry payments across SC — which companies pay providers there.
